Cargando…

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome

Objective. Polycystic ovary syndrome (PCOS) is associated with obesity and insulin resistance (IR), key features of nonalcoholic steatohepatitis (NASH). Cytokeratin 18 fragments (M30) have been established as a serum marker for NASH. The insulin sensitizer metformin improves hepatic IR. This study e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Susanne, Vollmar, Nils, Benson, Sven, Sowa, Jan-Peter, Bechmann, Lars P., Gerken, Guido, Fuhrer, Dagmar, Canbay, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383456/ https://www.ncbi.nlm.nih.gov/pubmed/25873949 http://dx.doi.org/10.1155/2015/254169

Ejemplares similares

Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure
por: Anastasiou, Olympia, et al.
Publicado: (2015)

From bedside to bench and back again—molecular mechanisms in acute liver failure
por: Sowa, Jan-Peter, et al.
Publicado: (2014)

Normal liver enzymes are correlated with severity of metabolic syndrome in a large population based cohort
por: Kälsch, Julia, et al.
Publicado: (2015)

SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
por: Mazzolini, Guillermo, et al.
Publicado: (2018)

Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD
por: Sowa, Jan-Peter, et al.
Publicado: (2013)

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
por: Lemmer, Peter, et al.
Publicado: (2022)

Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure
por: Manka, Paul, et al.
Publicado: (2013)

Non-alcoholic fatty liver disease in polycystic ovary syndrome women
por: Won, Young Bin, et al.
Publicado: (2021)

Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
por: Sydor, Svenja, et al.
Publicado: (2020)

Protective effect of astaxanthin and metformin in the liver of rats in which the polycystic ovary syndrome model was formed by giving letrozole
por: Taştan Bal, Tuğba, et al.
Publicado: (2023)

Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis
por: Sydor, Svenja, et al.
Publicado: (2017)

Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome
por: Arıkan, Didem, et al.
Publicado: (2022)

Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
por: Wang, Dongxu, et al.
Publicado: (2022)

Human Ex-Vivo Liver Model for Acetaminophen-induced Liver Damage
por: Schreiter, Thomas, et al.
Publicado: (2016)

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
por: Canbay, Ali, et al.
Publicado: (2019)

Low Levels of Blood Lipids Are Associated with Etiology and Lethal Outcome in Acute Liver Failure
por: Manka, Paul, et al.
Publicado: (2014)

In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter
por: Baars, Theodor, et al.
Publicado: (2016)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

A Rare Case of Propofol-Induced Acute Liver Failure and Literature Review
por: Kneiseler, G., et al.
Publicado: (2010)

Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
por: Riemann, Annika, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2017)

Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome
por: Chen, Yong, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome: A Race Against the Clock
por: Huffman, Alexandra M, et al.
Publicado: (2022)

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome
por: Kara, Ozlem, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC
por: Zhang, Yueqi, et al.
Publicado: (2021)

Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction
por: Baars, Theodor, et al.
Publicado: (2018)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

From the origin of NASH to the future of metabolic fatty liver disease
por: Geier, Andreas, et al.
Publicado: (2021)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease
por: Zhang, Jianhai, et al.
Publicado: (2018)

Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
por: Shengir, Mohamed, et al.
Publicado: (2020)

Long-Term Therapy of a Patient with Summerskill-Walshe-Tygstrup Syndrome by Applying Prometheus® Liver Dialysis: A Case Report
por: Walensi, Mikolaj, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s8q8k2n2nmpd8blp9gva312b3f